98%
921
2 minutes
20
With the growing prevalence of plastic use, the environmental release of plastic waste is escalating, and fragmented nanoscale plastic particles are emerging as significant environmental threats. This study aimed to evaluate the cytotoxic effects of fragmented polyethylene nanoplastics (PE NPs) manufactured using a focused ultrasonic system. The ultrasonic irradiation process generated fragmented PE NPs with a geometric mean diameter of 85.14 ± 5.37 nm and a size range of 25-350 nm. To assess cytotoxicity, we conducted a series of tests on various human cell lines, including stomach, blood, colon, lung, skin, liver, and brain-derived cells. The testing involved MTS-based cell viability assays to evaluate direct impacts on cell viability, lactate dehydrogenase (LDH) leakage assays to measure membrane damage, and ELISA to quantify TNF-α release as an indicator of inflammation. Although PE-NPs did not immediately induce apoptosis, significant LDH leakage and elevated TNF-α levels were observed across all cell lines, indicating membrane damage and inflammatory responses. Additionally, flow cytometry and TEM analyses revealed the intracellular accumulation of PE-NPs, further supporting their cytotoxic potential. These results demonstrate that fragmented PE-NPs can disrupt cellular membranes and induce inflammatory responses through accumulation within cells. The findings suggest that these NPs pose potential hazards to cell viability and underscore the need for further research into their environmental and health impacts.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.envpol.2024.125009 | DOI Listing |
J Biomed Sci
September 2025
Department of Biochemistry, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan.
Background: PPM1D (protein phosphatase Mg⁺/Mn⁺ dependent 1D) is a Ser/Thr phosphatase that negatively regulates p53 and functions as an oncogenic driver. Its gene amplification and overexpression are frequently observed in various malignancies and disruption of PPM1D degradation has also been reported as a cause of cancer progression. However, the precise mechanisms regulating PPM1D stability remain to be elucidated.
View Article and Find Full Text PDFInt J Hematol
September 2025
Bone Marrow Transplantation Center, the First Affiliated Hospital, Zhejiang University School of Medicine, No. 79 Qingchun Road, Hangzhou, 310003, China.
Patients with primary plasma cell leukemia (pPCL), particularly those with extramedullary disease (EMD), face a poor prognosis even with chimeric antigen receptor (CAR)-T cell therapy. This case report describes a patient with relapsed/refractory pPCL and life-threatening malignant pleural effusion (PE) treated with intrapleural CAR-T cells targeting B-cell maturation antigens. CAR-T cell expansion within the PE was observed, along with a rapid reduction in leukemia cell count and PE volume.
View Article and Find Full Text PDFVirchows Arch
September 2025
Department of Oral Surgery and Pathology, School of Dentistry, Universidade Federal de Minas Gerais, Minas Gerais, Av. Antônio Carlos, Pampulha, Belo Horizonte, 31270-901, Brazil.
Plasmablastic lymphoma (PBL) is a rare and aggressive non-Hodgkin lymphoma with a poor prognosis and short survival rates. It is classified as a large B-cell lymphoma subtype, but carries a plasmacytic immunophenotype. Therefore, PBL has pathogenetic overlaps with diffuse large B-cell lymphoma not otherwise specified (DLBCL NOS) and plasma cell neoplasms (PCNs).
View Article and Find Full Text PDFCancer Immunol Immunother
September 2025
Guangdong Provincial Clinical Research Center for Cancer, State Key Laboratory of Oncology in South China, Department of Thoracic Surgery, Sun Yat-Sen University Cancer Center, Guangdong Esophageal Cancer Institute, Guangzhou, 510060, China.
Background: Previous studies indicated that over-dissection of lymph nodes might impair the efficacy of immunotherapy. This study aims to explore the prognostic value of ypN + status and the impact of lymph node dissection (LND) on survival after neoadjuvant immunochemotherapy (NICT) for esophageal squamous cell cancer (ESCC).
Methods: This double-center retrospective study enrolled 206 consecutive ESCC patients who underwent NICT followed by esophagectomy between 2018 and 2024.
Cancer Immunol Immunother
September 2025
Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
Whole blood (WB) transcriptomics offers a minimal-invasive method to assess patients' immune system. This study aimed to identify transcriptional patterns in WB associated with clinical outcomes in patients treated with immune checkpoint inhibitors (ICIs). We performed RNA-sequencing on pre-treatment WB samples from 145 patients with advanced cancer.
View Article and Find Full Text PDF